PMID- 34414948 OWN - NLM STAT- MEDLINE DCOM- 20210902 LR - 20230103 IS - 1536-5964 (Electronic) IS - 0025-7974 (Print) IS - 0025-7974 (Linking) VI - 100 IP - 33 DP - 2021 Aug 20 TI - Long non-coding RNA as a potential biomarker for prognosis of glioma: A protocol for systematic review and meta-analysis. PG - e26921 LID - 10.1097/MD.0000000000026921 [doi] LID - e26921 AB - BACKGROUND: The molecular mechanism of Glioma is still unclear, and there are few early diagnostic markers. Therefore, it is urgent to figure out effective preventive measures, active diagnostic methods and rapid treatment measures. In recent years, relevant studies have revealed that long non-coding RNA (lncRNA) is associated with the prognosis of Glioma. However, these results have not been supported by any evidence. Therefore, this study carried out a meta-analysis method to analyze the relationship between lncRNA and the prognosis of Glioma. In addition, bioinformatics analysis was conducted to investigate the mechanism and related pathways of lncRNAs in Glioma. METHODS: We performed a systematic search in electronic databases, including China National Knowledge Infrastructure, Chinese Biomedical literature Database, Chinese Scientific and Journal Database, Wan Fang database, PubMed, EMBASE, Cochrane Library and Web of Science, to investigate the potential association between lncRNA expression and prognostic significance and clinical features in glioma patients. Hazards ratios (HRs) with corresponding 95% confidence intervals (CIs) were pooled to estimate the prognosis value of lncRNA by Stata16.0 software. The online tool AnnoLnc was applied to screen the co-expressed gene related to each lncRNA, David was used for gene ontology (GO) analysis and enrichment analysis of the signal pathway, and through Starbase, the possible competitive endogenous RNA network of lncRNAs was constructed. RESULTS: The results of this meta-analysis would be submitted to peer-reviewed journals for publication. CONCLUSION: This study will provide evidence-based medical evidence for lncRNA, so as to predict the prognosis of Glioma and bioinformatics analysis will provide ideas for the mechanism study on Glioma. CI - Copyright (c) 2021 the Author(s). Published by Wolters Kluwer Health, Inc. FAU - Xie, Teng AU - Xie T AD - Department of Neurosurgery, The People's Hospital of Hanchuan, Hanchuan, Hubei province, China. FAU - Li, Bin AU - Li B AD - Department of Neurosurgery, The People's Hospital of Hanchuan, Hanchuan, Hubei province, China. FAU - Liu, Huaming AU - Liu H AD - Department of Neurosurgery, The People's Hospital of Hanchuan, Hanchuan, Hubei province, China. FAU - Zhang, Chunwei AU - Zhang C AD - Department of Neurosurgery, The People's Hospital of Hanchuan, Hanchuan, Hubei province, China. FAU - Wang, Yanhua AU - Wang Y AD - Department of Neurosurgery, The People's Hospital of Hanchuan, Hanchuan, Hubei province, China. FAU - Chen, Zhijun AU - Chen Z AD - Department of Neurosurgery, The First People's Hospital of Jingmen, Jingmen, Hubei province, China. FAU - Yan, Junping AU - Yan J AUID- ORCID: 0000-0002-2988-2305 AD - Department of Neurosurgery, The People's Hospital of Hanchuan, Hanchuan, Hubei province, China. LA - eng GR - No. WJ2019M076/general project of natural science foundation of health commission of hubei province/ GR - No.2018CFB784/a grant from the general project of natural science foundation of science and technology department of hubei province/ GR - No.2019YFZD041/science and technology plan project of jingmen city hubei province/ PT - Journal Article PL - United States TA - Medicine (Baltimore) JT - Medicine JID - 2985248R RN - 0 (Biomarkers, Tumor) RN - 0 (RNA, Long Noncoding) SB - IM MH - Biomarkers, Tumor/*genetics MH - Glioma/*genetics MH - Humans MH - *Meta-Analysis as Topic MH - Prognosis MH - RNA, Long Noncoding/*genetics MH - *Research Design MH - Systematic Reviews as Topic/*methods PMC - PMC8376343 COIS- The authors have no conflicts of interest to disclose. EDAT- 2021/08/21 06:00 MHDA- 2021/09/03 06:00 PMCR- 2021/08/20 CRDT- 2021/08/20 09:05 PHST- 2021/07/21 00:00 [received] PHST- 2021/07/27 00:00 [accepted] PHST- 2021/08/20 09:05 [entrez] PHST- 2021/08/21 06:00 [pubmed] PHST- 2021/09/03 06:00 [medline] PHST- 2021/08/20 00:00 [pmc-release] AID - 00005792-202108200-00018 [pii] AID - MD-D-21-05173 [pii] AID - 10.1097/MD.0000000000026921 [doi] PST - ppublish SO - Medicine (Baltimore). 2021 Aug 20;100(33):e26921. doi: 10.1097/MD.0000000000026921.